The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

79 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-01

Study Completion Date

2017-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Walking is encouraged for people with type 2 diabetes but there is little evidence that performing a bout of walking can improve glucose control. Furthermore, it is unknown how participant characteristics (e.g., age, sex, medications) impact the acute glucose responses to walking in people with type 2 diabetes. The primary purpose of this study is to examine how a standardized bout of walking impacts glucose control assessed over 24 hours using continuous glucose monitoring. A secondary purpose is to determine whether responses are influenced by age, sex, and medication use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes

NCT05029804

Diabetes Mellitus, Type 2 Exercise Walking Pneumonia +1 more

UNKNOWN NA

Web-based Dietary Intervention for Diabetic Patients

NCT01246687

Diabetes Mellitus, Type 2 Intervention Studies Behavior

COMPLETED NA

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

NCT02980978

Diabetes Mellitus, Type 2

COMPLETED NA

The Integration of Physical Activity Into the Clinical Decision Process of People with Type 1 Diabetes

NCT05670366

Type 1 Diabetes

COMPLETED NA

Online Support for Diabetes Self-Management

NCT02504086

Diabetes Mellitus Type 2

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Walking Seated Control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Walking

Walking on a treadmill at 3.5 metabolic equivalents (METS) for 50 minutes

Group Type EXPERIMENTAL

Walking

Intervention Type BEHAVIORAL

Walking on a treadmill at 3.5 METS for 50 minutes

Seated Control

Sitting for 50 minutes

Group Type EXPERIMENTAL

Seated Control

Intervention Type BEHAVIORAL

Sitting for 50 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Walking

Walking on a treadmill at 3.5 METS for 50 minutes

Intervention Type BEHAVIORAL

Seated Control

Sitting for 50 minutes

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with T2D for more than 6 months
* 30-90 years of age
* No contra-indications to exercise (PAR-Q+, Rose Angina questionnaire, limited ability to walk for 50 min).
* No previous myocardial infarction, stroke or diagnosed coronary artery disease
* No changes in diabetes medication in last 3 months
* Not treated by insulin or corticosteroids
* No significant change in body weight (\>5%) in last 3 months
* Blood pressure \<160/100 mmHg; resting HR\<100
* Able to understand English or French and comply with study requirements (e.g., attend visits during the day)
* Hemoglobin A1C \<9.0%
* No prior history of hypoglycaemia during activity or sleep

Exclusion Criteria

* Chest pain during physical activity.
* Chest pain while resting (no physical activity) in the past month.
* Loss of balance or consciousness because of dizziness in past 12 months
* Bone or joint problem (for example, back, knee, or hip) that could be made worse by a change in physical activity.
* Currently pregnant or planning on becoming pregnant in the next 3 months
* Currently taking exogenous insulin
* Previous heart attack or stroke
* Any other reason that prevents ability to walk on a treadmill for 50 minutes

Minimum Eligible Age

30 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No